Biologik ApS: Financial statements 2026
CVR: 36070498
Source: annual report 2026, Danish Business Authority
01/07/2025 – 30/06/2026
Biologik ApS (CVR 36070498) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK 1,028,840 and a net result of DKK 805,458 compared with DKK 234,499 the year before. That is an increase of 166.8% compared with the year before. Equity in the 2026 report amounted to DKK 1,150,734. The solvency ratio was 95.8%.
- Gross Profit
- DKK 1,028,840
- Profit/Loss
- DKK 805,458
- Equity
- DKK 1,150,734
- Total Assets
- DKK 1,200,577
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2026 | - | 1M | 805K | 1.2M | 0 |
| 2025 | - | 386K | 234K | 409K | 1 |
| 2024 | - | 400K | -35K | 235K | 1 |
| 2023 | - | 653K | 119K | 329K | 1 |
| 2022 | - | 258K | -89K | 268K | 1 |
Official annual report
Find more companies like Biologik ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorAbout Biologik ApS
Biologik ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2014. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The company was previously named EPOQE ApS. The management consists of Anette Sams Nielsen. The company is owned by Helms & Sams ApS. The company has 1 employee (2024). In 2026, the company reported a gross profit of DKK 1,028,840 and a net result of DKK 805,458 compared with DKK 234,499 the year before. Equity in the 2026 report amounted to DKK 1,150,734.